| Code | Description | Claims | Beneficiaries | Total Paid |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
11,364 |
9,612 |
$254K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
12,525 |
11,207 |
$114K |
| 99305 |
|
1,057 |
886 |
$21K |
| 99304 |
|
1,584 |
1,400 |
$20K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
946 |
823 |
$13K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,524 |
1,333 |
$10K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
695 |
598 |
$9K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
272 |
244 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
446 |
343 |
$7K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
597 |
543 |
$5K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
235 |
191 |
$3K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
24 |
24 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
130 |
125 |
$2K |
| 90688 |
|
120 |
115 |
$1K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
257 |
233 |
$990.26 |
| 90686 |
|
83 |
77 |
$984.77 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
216 |
105 |
$982.98 |
| 90656 |
|
128 |
123 |
$858.75 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
19 |
15 |
$543.68 |
| 90661 |
|
17 |
17 |
$324.40 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
17 |
17 |
$234.00 |
| 36415 |
Collection of venous blood by venipuncture |
165 |
163 |
$118.80 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
14 |
14 |
$0.00 |
| 1125F |
|
71 |
62 |
$0.00 |
| 1126F |
|
80 |
78 |
$0.00 |
| 1111F |
|
26 |
26 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
36 |
34 |
$0.00 |